kymriah-rems.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | REMS Safety |
| Description | Risk Evaluation and Mitigation KYMRIAH ( tisagenlecleucel) Suspension for IV infusion Risk Evaluation and Mitigation Strategy (REMS) Kymriah Prescribing Information Kymriah Medication G |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 217.114.85.100 |
| Location | Sweden |
Related Websites
| Site | Rank |
More to Explore
kymriah-rems.com Valuation
|
US$7,617,769
Last updated: 2023-05-12 22:52:03
kymriah-rems.com has Semrush global rank of 1,389,423. kymriah-rems.com has an estimated worth of US$ 7,617,769, based on its estimated Ads revenue. kymriah-rems.com receives approximately 878,974 unique visitors each day. Its web server is located in Sweden, with IP address 217.114.85.100. According to SiteAdvisor, kymriah-rems.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$7,617,769 |
| Daily Ads Revenue | US$7,032 |
| Monthly Ads Revenue | US$210,954 |
| Yearly Ads Revenue | US$2,531,444 |
| Daily Unique Visitors | 58,599 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| kymriah-rems.com. | A | 7199 | IP: 217.114.85.100 |
| kymriah-rems.com. | NS | 1800 | NS Record: dns2.novartis.com. |
| kymriah-rems.com. | NS | 1800 | NS Record: a28-67.akam.net. |
| kymriah-rems.com. | NS | 1800 | NS Record: dns1.novartis.com. |
| kymriah-rems.com. | NS | 1800 | NS Record: a1-254.akam.net. |
| kymriah-rems.com. | NS | 1800 | NS Record: a7-64.akam.net. |
| kymriah-rems.com. | NS | 1800 | NS Record: a2-66.akam.net. |
| kymriah-rems.com. | NS | 1800 | NS Record: a24-65.akam.net. |
| kymriah-rems.com. | NS | 1800 | NS Record: dns4.novartis.com. |
| kymriah-rems.com. | NS | 1800 | NS Record: a9-65.akam.net. |
| kymriah-rems.com. | NS | 1800 | NS Record: dns3.novartis.com. |
HtmlToTextCheckTime:2023-05-12 22:52:03
| KYMRIAH ( tisagenlecleucel) Suspension for IV infusion Risk Evaluation and Mitigation Strategy (REMS) Kymriah Prescribing Information Kymriah Medication Guide Kymriah REMS Live Training Program Slides Kymriah REMS Program Knowledge Assessment Kymriah REMS Program Patient Wallet Card Kymriah REMS Program Patient Wallet Card (Español) INDICATION: Kymriah is a CD19-directed genetically modified autologous T Cell immunotherapy indicated for the treatment of: Patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse. Adult patients with relapsed or refractory (r/r) large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, high grade B-cell lymphoma and DLBCL arising from follicular lymphoma. Limitation of Use: KYMRIAH is not indicated for treatment of patients with primary central nervous system lymphoma. Adult patients with |
HTTP Headers
HTTP/1.0 301 Moved Permanently Location: https://www.kymriah-rems.com/ Server: BigIP Connection: Keep-Alive Content-Length: 0 HTTP/2 200 date: Mon, 20 Dec 2021 04:57:40 GMT content-type: text/html; charset=utf-8 cache-control: private vary: Accept-Encoding set-cookie: ASP.NET_SessionId=lcl1acrnlfaudflwxxyhgeih; path=/; secure; HttpOnly; SameSite=Lax content-security-policy: default-src 'self' 'unsafe-inline' 'unsafe-eval' fonts.googleapis.com fonts.gstatic.com www.googletagmanager.com www.google-analytics.com unpkg.com s.usea01.idio.episerver.net a.usea01.idio.episerver.net stats.g.doubleclick.net analytics.google.com api.fouanalytics.com *.vo.msecnd.net dc.services.visualstudio.com *.b2c.com bat.bing.com request-context: appId=cid-v1:fbded6d8-2f5c-4cb0-adf7-2ae9d814644f access-control-expose-headers: Request-Context x-xss-protection: 1; mode=block x-content-type-options: nosniff strict-transport-security: max-age=31536000; includeSubDomains x-frame-options: SAMEORIGIN set-cookie: ASP.NET_SessionId=lcl1acrnlfaudflwxxyhgeih; path=/; secure; HttpOnly; SameSite=Lax set-cookie: __RequestVerificationToken=v64UKP9yVQegqw8YtskXk4gL6eodAJ3BTqWIS3Yxny1MBq4cLruOxK25sweqxzoFzVFefDGXtgaDjtBxt_4dzOIMaI99WoOsypxdu6bT0Rw1; path=/; secure; HttpOnly set-cookie: ARRAffinity=b7e72dec7e4cc8a4736179c6176e926e1a9bf791a689d53c7c98cb9379127d31;Path=/;HttpOnly;Secure;Domain=www.kymriah-rems.com set-cookie: ARRAffinitySameSite=b7e72dec7e4cc8a4736179c6176e926e1a9bf791a689d53c7c98cb9379127d31;Path=/;HttpOnly;SameSite=None;Secure;Domain=www.kymriah-rems.com cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 6c064a8c2c631988-EWR |
kymriah-rems.com Whois Information
Domain Name: KYMRIAH-REMS.COM Registry Domain ID: 2040948420_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-06-06T09:04:45Z Creation Date: 2016-07-07T20:55:15Z Registry Expiry Date: 2023-07-07T20:55:15Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: A1-254.AKAM.NET Name Server: A2-66.AKAM.NET Name Server: A24-65.AKAM.NET Name Server: A28-67.AKAM.NET Name Server: A7-64.AKAM.NET Name Server: A9-65.AKAM.NET Name Server: DNS1.NOVARTIS.COM Name Server: DNS2.NOVARTIS.COM Name Server: DNS3.NOVARTIS.COM Name Server: DNS4.NOVARTIS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-23T08:41:08Z <<< |